Literature DB >> 32516508

ERAS for Head and Neck Tissue Transfer Reduces Opioid Usage, Peak Pain Scores, and Blood Utilization.

Bhavishya S Clark1, Mark Swanson1, William Widjaja2, Brian Cameron3, Valerie Yu2, Ksenia Ershova2, Franklin M Wu3, Erik B Vanstrum3, Ruben Ulloa3, Andrew Heng3, Margaret Nurimba3, Niels Kokot1, Amit Kochhar1, Uttam K Sinha1, M P Kim2, Shane Dickerson4.   

Abstract

OBJECTIVES: We implement a novel enhanced recovery after surgery (ERAS) protocol with pre-operative non-opioid loading, total intravenous anesthesia, multimodal peri-operative analgesia, and restricted red blood cell (pRBC) transfusions. 1) Compare differences in mean postoperative peak pain scores, opioid usage, and pRBC transfusions. 2) Examine changes in overall length of stay (LOS), intensive care unit LOS, complications, and 30-day readmissions.
METHODS: Retrospective cohort study comparing 132 ERAS vs. 66 non-ERAS patients after HNC tissue transfer reconstruction. Data was collected in a double-blind fashion by two teams.
RESULTS: Mean postoperative peak pain scores were lower in the ERAS group up to postoperative day (POD) 2. POD0: 4.6 ± 3.6 vs. 6.5 ± 3.5; P = .004) (POD1: 5.2 ± 3.5 vs. 7.3 ± 2.3; P = .002) (POD2: 4.1 ± 3.5 vs. 6.6 ± 2.8; P = .000). Opioid utilization, converted into morphine milligram equivalents, was decreased in the ERAS group (POD0: 6.0 ± 9.8 vs. 10.3 ± 10.8; P = .010) (POD1: 14.1 ± 22.1 vs. 34.2 ± 23.2; P = .000) (POD2: 11.4 ± 19.7 vs. 37.6 ± 31.7; P = .000) (POD3: 13.7 ± 20.5 vs. 37.9 ± 42.3; P = .000) (POD4: 11.7 ± 17.9 vs. 36.2 ± 39.2; P = .000) (POD5: 10.3 ± 17.9 vs. 35.4 ± 45.6; P = .000). Mean pRBC transfusion rate was lower in ERAS patients (2.1 vs. 3.1 units, P = .017). There were no differences between ERAS and non-ERAS patients in hospital LOS, ICU LOS, complication rates, and 30-day readmissions.
CONCLUSION: Our ERAS pathway reduced postoperative pain, opioid usage, and pRBC transfusions after HNC reconstruction. These benefits were obtained without an increase in hospital or ICU LOS, complications, or readmission rates. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E792-E799, 2021.
© 2020 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  ERAS; Enhanced recovery after surgery; free tissue transfer; head and neck cancer; restricted blood transfusion; total intravenous anesthesia

Mesh:

Substances:

Year:  2020        PMID: 32516508     DOI: 10.1002/lary.28768

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Adoption of enhanced surgical recovery (ESR) protocol for adult spinal deformity (ASD) surgery decreases in-hospital and 90-day post-operative opioid consumption.

Authors:  Ehsan Jazini; Alexandra E Thomson; Andre D Sabet; Omar Sohail; Leah Y Carreon; Lindsay Orosz; Fenil R Bhatt; Rita Roy; Colin M Haines; Thomas C Schuler; Christopher R Good
Journal:  Spine Deform       Date:  2021-11-06

Review 2.  Implementation of an enhanced recovery after surgery protocol for head and neck cancer patients: Considerations and best practices.

Authors:  Aman Prasad; Kevin Chorath; Louis-Xavier Barrette; Beatrice Go; Jie Deng; Alvaro Moreira; Karthik Rajasekaran
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-06

3.  Enhanced recovery after microvascular reconstruction in head and neck cancer - A prospective study.

Authors:  Jens H Højvig; Birgitte W Charabi; Irene Wessel; Lisa T Jensen; Jan Nyberg; Nana Maymann-Holler; Henrik Kehlet; Christian T Bonde
Journal:  JPRAS Open       Date:  2022-08-19

Review 4.  Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Head and Neck Cancer.

Authors:  Anirudh Saraswathula; Christine G Gourin; Peter S Vosler
Journal:  Ann Surg Oncol       Date:  2021-04-23       Impact factor: 4.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.